Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Name: Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

breastcancer coloncancer lungcancer neoplasms prostatecancer

neoplasms, prostate cancer, lung cancer, breast cancer, colon cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127593
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.